FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155192018> ?p ?o ?g. }

• W2155192018 endingPage "174" @default.
• W2155192018 startingPage "174" @default.
• W2155192018 abstract "Each year in the developed world 100 million patients acquire scars, some of which cause considerable problems, as a result of 55 million elective operations and 25 million operations after trauma. There are an estimated 11 million keloid scars and four million burn scars, 70% of which occur in children. Radiation was first used for treating keloids in 1906, however the debate on how safe this practice is still continues.Treating benign conditions with high energy radiation is not something that physicians would agree to lightly, so why do we still do it? Keloid scars are the commonest benign disease treated with radiation therapy at this point in our history. We have in the past treated many other benign conditions but we now know the long term risks of giving unnecessary radiation.What other benign conditions have we treated in the past? What are the long term risks of radiation treatment? Do all keloid scars need radiation therapy? How low a dose can we use and what energy would serve us best? Are there safer options when treating keloid scars than using radiation therapy? At what point would you, the audience, take the risk of radiation induced long term side effects, (while looking at various keloid images)?We conclude that the risk of carcinogenesis attributable to keloid radiation therapy is very low when surrounding tissues, especially in children and infants, are adequately protected, and that radiation therapy is acceptable as a keloid treatment modality. Botwood 1999 “Whilst there are no other satisfactory solutions to troublesome keloids, radiotherapy seems destined to remain the mainstay of treatment.” Each year in the developed world 100 million patients acquire scars, some of which cause considerable problems, as a result of 55 million elective operations and 25 million operations after trauma. There are an estimated 11 million keloid scars and four million burn scars, 70% of which occur in children. Radiation was first used for treating keloids in 1906, however the debate on how safe this practice is still continues. Treating benign conditions with high energy radiation is not something that physicians would agree to lightly, so why do we still do it? Keloid scars are the commonest benign disease treated with radiation therapy at this point in our history. We have in the past treated many other benign conditions but we now know the long term risks of giving unnecessary radiation. What other benign conditions have we treated in the past? What are the long term risks of radiation treatment? Do all keloid scars need radiation therapy? How low a dose can we use and what energy would serve us best? Are there safer options when treating keloid scars than using radiation therapy? At what point would you, the audience, take the risk of radiation induced long term side effects, (while looking at various keloid images)? We conclude that the risk of carcinogenesis attributable to keloid radiation therapy is very low when surrounding tissues, especially in children and infants, are adequately protected, and that radiation therapy is acceptable as a keloid treatment modality. Botwood 1999 “Whilst there are no other satisfactory solutions to troublesome keloids, radiotherapy seems destined to remain the mainstay of treatment.”" @default.
• W2155192018 created "2016-06-24" @default.
• W2155192018 creator A5074803934 @default.
• W2155192018 date "2014-06-01" @default.
• W2155192018 modified "2023-10-18" @default.
• W2155192018 title "Do We Still Treat Benign Conditions with Radiation?" @default.
• W2155192018 doi "https://doi.org/10.1016/j.jmir.2014.03.044" @default.
• W2155192018 hasPublicationYear "2014" @default.
• W2155192018 type Work @default.
• W2155192018 sameAs 2155192018 @default.
• W2155192018 citedByCount "0" @default.
• W2155192018 crossrefType "journal-article" @default.
• W2155192018 hasAuthorship W2155192018A5074803934 @default.
• W2155192018 hasConcept C127413603 @default.
• W2155192018 hasConcept C141071460 @default.
• W2155192018 hasConcept C16005928 @default.
• W2155192018 hasConcept C2777538232 @default.
• W2155192018 hasConcept C2777642821 @default.
• W2155192018 hasConcept C2985973956 @default.
• W2155192018 hasConcept C509974204 @default.
• W2155192018 hasConcept C61696701 @default.
• W2155192018 hasConcept C71924100 @default.
• W2155192018 hasConceptScore W2155192018C127413603 @default.
• W2155192018 hasConceptScore W2155192018C141071460 @default.
• W2155192018 hasConceptScore W2155192018C16005928 @default.
• W2155192018 hasConceptScore W2155192018C2777538232 @default.
• W2155192018 hasConceptScore W2155192018C2777642821 @default.
• W2155192018 hasConceptScore W2155192018C2985973956 @default.
• W2155192018 hasConceptScore W2155192018C509974204 @default.
• W2155192018 hasConceptScore W2155192018C61696701 @default.
• W2155192018 hasConceptScore W2155192018C71924100 @default.
• W2155192018 hasIssue "2" @default.
• W2155192018 hasLocation W21551920181 @default.
• W2155192018 hasOpenAccess W2155192018 @default.
• W2155192018 hasPrimaryLocation W21551920181 @default.
• W2155192018 hasRelatedWork W1996201445 @default.
• W2155192018 hasRelatedWork W2011177479 @default.
• W2155192018 hasRelatedWork W2020439718 @default.
• W2155192018 hasRelatedWork W2088853187 @default.
• W2155192018 hasRelatedWork W2809880625 @default.
• W2155192018 hasRelatedWork W2905784497 @default.
• W2155192018 hasRelatedWork W3028822308 @default.
• W2155192018 hasRelatedWork W3099786641 @default.
• W2155192018 hasRelatedWork W3211155081 @default.
• W2155192018 hasRelatedWork W4321437972 @default.
• W2155192018 hasVolume "45" @default.
• W2155192018 isParatext "false" @default.
• W2155192018 isRetracted "false" @default.
• W2155192018 magId "2155192018" @default.
• W2155192018 workType "article" @default.